Planet Labs PBC (PL) co-founder gifts 55,000 Class A shares
Robert H. Schingler, Co-Founder and Chief Strategy Officer of Planet Labs PBC (PL), reported a bona fide gift of 55,000 Class A Common Stock shares on August 5, 2026, from the Ulysses Trust 02021.1, for which no value was received. Following this transaction, the trust indirectly holds 170,171 shares, while Schingler directly holds 825,541 shares, including 744,984 RSUs that vest quarterly. These transactions were conducted under a Rule 10b5-1 trading plan.
What Does Planet Labs CFO Ashley Johnson's Sale of Shares Worth $2.4 Million Mean for Investors?
Planet Labs CFO Ashley Johnson sold approximately 110,000 shares worth $2.4 million on July 23, 2026, as part of a pre-established Rule 10b5-1 trading plan. Despite the sale occurring during a stock decline, it is not seen as a red flag because Johnson retains a significant equity position, aligning her interests with shareholders. The company experienced a 226% one-year return but also reported a substantial net loss in the trailing-twelve-month period.
What Does Planet Labs CFO Ashley Johnson's Sale of Shares Worth $2.4 Million Mean for Investors?
Planet Labs CFO Ashley Johnson sold approximately 110,000 shares of Class A Common Stock for $2.4 million on July 23, 2026, under a pre-established Rule 10b5-1 trading plan. This transaction, which occurred during a period of declining stock prices for Planet Labs, reduced her total equity holdings by 6% but is not seen as a red flag for investors due to its non-discretionary nature and her significant remaining equity. Planet Labs, which reported a 226% one-year return, generated $335.6 million in revenue and a net loss of $373.1 million in the trailing twelve months.
BlackRock (PL) discloses 14.18M Planet Labs shares with sole dispositive power
BlackRock, Inc. has filed an amended Schedule 13G/A, disclosing its beneficial ownership of 14,179,036 shares of Planet Labs PBC Class A stock, which constitutes a 4.3% stake in the company. BlackRock holds sole voting power over 13,626,744 shares and sole dispositive power over all 14,179,036 shares. No single underlying client holds more than five percent of Planet Labs' outstanding common shares, and the filing was signed by Managing Director Spencer Fleming on July 29, 2026.
Planet Labs PBC President and CFO Ashley F. Johnson Executes Share Transfers Under Rule 10b5-1 Plan
Planet Labs PBC's President and CFO, Ashley F. Johnson, has engaged in significant share transactions under a Rule 10b5-1 trading plan. These transactions are relevant to investors as they highlight executive actions and could impact shareholder value, reflecting changes in the management's ownership structure.
Planet Labs PBC (PL) CFO sells 110,028 shares under Rule 10b5-1 plan
Planet Labs PBC's President and CFO, Ashley F. Johnson, reported selling a total of 110,028 Class A shares on July 23, 2026. These transactions, including direct sales and sales from a revocable trust, were conducted under a Rule 10b5-1 trading plan adopted in April 2026, at a weighted average price of $22.0804 per share. Johnson still retains 1,132,122 RSUs that vest quarterly.
Planet Labs President, CFO Ashley F. Johnson sells USD 2.43 million in common shares
Planet Labs President and CFO Ashley F. Johnson sold 75,035 Class A shares at a weighted average price of $22.08 on July 23, 2026. Additionally, 34,993 shares held by the Johnson Joint Revocable Trust were also sold at the same price. Following these transactions, Johnson directly holds 1,132,122 Class A shares, and 70,767 Class A shares were transferred into the Johnson Joint Revocable Trust, which now holds 596,475 shares.
A Planet Labs Director Sold Over 6,000 Shares Amid a 323% Stock Rally. What Does That Mean for Investors?
A director at Planet Labs PBC, John W. Raymond, sold 6,494 shares for approximately $169,883 on July 13, 2026, as part of a pre-established Rule 10b5-1 plan. This transaction, which reduced his holdings by 13%, occurred after the stock experienced a 323% return over the past year. The article suggests this sale is not a cause for investor concern as it was non-discretionary and Raymond still maintains a significant indirect stake in the company.
Planet Labs PBC (PL) stock price, news, quote and history
This article from Yahoo Finance provides a comprehensive overview of Planet Labs PBC (PL) stock, including its current price, historical performance, key financial statistics, and analyst ratings. It details the company's business activities in aerospace and defense, focusing on its satellite constellations for geospatial data and Earth imaging. The report also includes performance metrics against the S&P 500 benchmark, earnings trends, and valuation measures.
A Planet Labs Director Sold Over 6,000 Shares Amid a 323% Stock Rally. What Does That Mean for Investors?
John W. Raymond, a director at Planet Labs PBC (NYSE:PL), sold 6,494 shares for roughly $169,883 on July 13, 2026, as part of a pre-established Rule 10b5-1 plan. Despite a significant 323% stock rally over the preceding year, this transaction is considered non-discretionary and does not imply insider concerns about future share price appreciation, especially since Raymond moved a substantial portion of his holdings into a trust, retaining over 37,000 indirect shares. The sale occurred after the stock surged to a 52-week high in anticipation of the SpaceX IPO, subsequently falling back to lower levels.
A Planet Labs Director Sold Over 6,000 Shares Amid a 323% Stock Rally. What Does That Mean for Investors?
A director at Planet Labs PBC, John W. Raymond, sold 6,494 shares for approximately $169,883 on July 13, 2026. This transaction was part of a pre-established Rule 10b5-1 plan and reduced his directly held equity by 13% but he still retains a significant indirect stake. The sale occurred after the stock experienced a 323% rally over the preceding year, peaking with the anticipation of the SpaceX IPO, and is not seen as a cause for investor concern.
A Planet Labs Director Sold Over 6,000 Shares Amid a 323% Stock Rally. What Does That Mean for Investors?
A Planet Labs PBC director, John W. Raymond, sold 6,494 shares for approximately $169,883 on July 13, 2026, as part of a pre-established Rule 10b5-1 plan. This transaction occurred while the company's stock had seen a 323% increase over the past year. Analysts suggest this non-discretionary sale, along with his substantial remaining indirect holdings in a trust, does not indicate a negative outlook for investors.
Planet Labs director Kristen Robinson sells $929k in stock
Planet Labs director Kristen Robinson sold 37,107 shares of Class A Common Stock for $929,637 on July 15, 2026, under a Rule 10b5-1 trading plan. The transaction occurred as the stock saw an 8.5% decline over the past week, despite a 286% increase over the last year. Following this, she indirectly holds 222,897 shares and directly holds 6,479 shares, with Needham recently raising its price target for Planet Labs to $53.
Planet Labs director Kristen Robinson sells $929k in stock
Kristen Robinson, a director at Planet Labs PBC, sold 37,107 shares of Class A Common Stock worth $929,637 on July 15, 2026, through a pre-arranged trading plan. This transaction occurred amidst an 8.5% decline in the stock over the past week, although shares are up 286% year-over-year. The sale and subsequent transfer of shares to a trust highlight insider activity while an InvestingPro analysis suggests the stock might be overvalued.
Planet Labs director Kristen Robinson sells $929k in stock By Investing.com
Planet Labs director Kristen Robinson sold 37,107 shares of Class A Common Stock worth $929,637 on July 15, 2026, through a Rule 10b5-1 trading plan. This transaction occurred as the stock had recently declined but remained significantly up over the last year. Concurrently, Ms. Robinson transferred an identical number of shares to a family trust, altering her direct and indirect holdings.
Planet Labs PBC (NYSE: PL) director sells 37,107 shares in planned trade
Planet Labs PBC director Kristen Robinson sold 37,107 shares of Class A Common Stock at a weighted-average price of $25.0529 per share under a Rule 10b5-1 trading plan. The transaction involved a transfer of shares to The Gary and Kristen Robinson Trust, where she serves as a trustee, and resulted in her holding 260,004 shares indirectly and 6,479 shares directly after the transactions. The sale, valued at approximately $930,000, was executed in multiple trades with prices ranging from $24.31 to $26.45.
Planet Labs director Raymond sells $169,871 in stock
John Raymond, a director at Planet Labs PBC, sold 6,494 shares of Class A Common Stock for $169,871 on July 13, 2026, as part of a pre-arranged trading plan. Prior to the sale, Raymond transferred 43,608 shares to a family trust, which then executed the sale and now holds 37,114 shares. This transaction follows other company news, including strong Q1 fiscal 2027 results and strategic partnerships.
Planet Labs (PL) director granted over 8,600 RSUs in latest Form 4 filing
Planet Labs PBC director Gary B. Smith was granted 8,639 Restricted Stock Units (RSUs) as equity compensation, according to a recent Form 4 filing. These RSUs are divided into two tranches: 2,160 RSUs vesting quarterly and 6,479 RSUs with a cliff vest schedule tied to the first anniversary of the grant or the next annual stockholder meeting. This transaction reflects standard board compensation and is not an open-market purchase.
Planet Labs director Raymond sells $169,871 in stock By Investing.com
John Raymond, a director at Planet Labs PBC (NYSE:PL), sold 6,494 shares of the company’s Class A Common Stock for $169,871 on July 13, 2026, as part of a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $26.1582, with prices ranging from $25.69 to $26.89. This transaction followed a transfer of shares to the Raymond Family Rev Trust, which now holds 37,114 shares.
Insider trust sale and share transfers at Planet Labs PBC (PL)
Planet Labs PBC director Raymond John w reported an open-market sale of 6,494 Class A shares on July 13, 2026, at a weighted average price of $26.1582, executed by the Raymond Family Rev Trust under a Rule 10b5-1 trading plan. Additionally, 43,608 shares were reclassified between his direct holdings and the trust. Following these transactions, John w holds 37,114 shares indirectly through the trust and 6,479 shares directly.
Planet Labs co-founder and CEO Marshall William Spencer sells $5.18m in stock
Marshall William Spencer, co-founder and CEO of Planet Labs PBC (PL), sold 200,000 shares of the company's Class A Common Stock for approximately $5.18 million. This sale, executed via a Rule 10b5-1 trading plan, occurred while the company's stock had declined 9.4% in the prior week but was up 319% over the past year. Post-transaction, Spencer retains over 2.7 million shares, including restricted stock units, as Planet Labs continues to see significant developments and analyst support despite an InvestingPro assessment suggesting it is overvalued.
Planet Labs (NYSE: PL) co-founder sells shares under 10b5-1 plan
Planet Labs PBC co-founder and Chief Strategy Officer Robert H. Schingler sold a total of 89,593 shares of Class A Common Stock for $25.9197 per share on July 10, 2026. These sales, executed under a Rule 10b5-1 trading plan adopted in July 2025, included shares from both his direct holdings and those held by the Ulysses Trust 02021.1. Following these transactions, Schingler retains significant holdings, including direct shares, indirect shares through the trust, and 744,984 RSUs that vest quarterly.
Planet Labs co-founder and CEO Marshall William Spencer sells $5.18m in stock By Investing.com
Planet Labs co-founder and CEO Marshall William Spencer sold 200,000 shares of Class A Common Stock for approximately $5.18 million on July 10, 2026, as part of a Rule 10b5-1 trading plan. The sale occurred after the stock's 9.4% decline over the past week, although shares are up 319% over the past year. Spencer still directly holds over 2.7 million shares, including restricted stock units.
Planet Labs co-founder and CEO Marshall William Spencer sells $5.18m in stock By Investing.com
Marshall William Spencer, co-founder and CEO of Planet Labs PBC (PL), sold 200,000 shares of Class A Common Stock for approximately $5.18 million. The sale occurred on July 10, 2026, at an average price of $25.9197 per share, in accordance with a Rule 10b5-1 trading plan adopted in July 2025. Despite a recent 9.4% decline, the stock is up 319% over the past year, though InvestingPro analysis suggests it may be overvalued.
Planet Labs PBC (NYSE: PL) director Kristen Robinson granted 6,479 RSUs, updates holdings
Planet Labs PBC director Kristen Robinson was granted 6,479 restricted stock units (RSUs) as equity compensation, with a grant price of $0.00 per share. These RSUs will fully vest on the earlier of the first anniversary of the grant or the company's next annual meeting of stockholders, contingent on continuous service. Following this grant, Robinson directly holds 43,586 shares and indirectly holds 222,897 shares through The Gary and Kristen Robinson Trust, indicating a significant stake in the company.
Planet Labs shareholders reinforce governance and board continuity
Planet Labs PBC shareholders reinforced governance and board continuity at their 2026 Annual Meeting. They re-elected three Class II directors for three-year terms and ratified KPMG LLP as the independent auditor. Shareholders also approved executive compensation on a non-binding advisory basis, indicating strong alignment with the company's governance and pay practices.
Planet Labs (PL) director receives 2,736 and 6,479 RSU awards in Form 4 filing
Planet Labs PBC director Brennan Ita M reported receiving two equity compensation awards in the form of restricted stock units (RSUs) as detailed in a recent Form 4 filing. These awards consist of 2,736 RSUs with quarterly vesting and 6,479 RSUs that will vest fully on the earlier of one year from the grant date or the next annual stockholders' meeting, both contingent on continuous service. This reflects standard director compensation aimed at aligning interests with shareholders and does not involve any open-market purchases or sales.
Planet Labs PBC (NYSE: PL) director Reese Scott granted 8,639 RSUs
Planet Labs PBC director Reese Scott was granted a total of 8,639 Restricted Stock Units (RSUs) in two separate equity awards. One grant of 2,160 RSUs will vest in equal quarterly installments, while the other grant of 6,479 RSUs will fully vest on the earlier of one year from the grant date or the next annual stockholders' meeting, both subject to continuous service. These grants represent a contingent right to receive Class A Common Stock, with no expiration date for the RSUs themselves.
Planet Labs (PL) director Vijaya Gadde awarded 6,479 RSUs in new equity grant
Planet Labs PBC director Vijaya Gadde was granted 6,479 restricted stock units (RSUs), representing shares of Class A Common Stock, as routine equity compensation. These RSUs will vest fully on the earlier of the first anniversary of the grant or the next annual stockholders' meeting, provided continuous service is maintained. Following this grant, Gadde directly holds 256,648 shares, indicating the award is incremental to existing holdings and not a thesis-changing event.
Planet Labs (NYSE: PL) grants director 6,479 RSUs, taking holdings to 50,087 shares
Planet Labs PBC announced that director Raymond John w received a grant of 6,479 restricted stock units (RSUs) of Class A Common Stock. These RSUs will vest fully on the earlier of the first anniversary of the grant or the next annual meeting of stockholders, contingent on his continuous service. Following this grant, Raymond John w's direct holdings in Planet Labs amount to 50,087 shares of Class A Common Stock, including the newly awarded RSUs.
Planet Labs PBC Class A (PL) Stock Price | Live Quotes & Charts | NYSE
This article provides live quotes and charts for Planet Labs PBC Class A (PL) stock, showing its current price as $27.41, down by $0.34 or 1.22%. It also includes a section indicating no current analyst ratings or earnings information for the company. The page features various trading resources and disclaimers about the risks and profitability of day trading.
Planet Labs PBC (NYSE: PL) shareholders approve directors, KPMG and pay plan
Planet Labs PBC shareholders approved the re-election of three Class II directors, ratified KPMG LLP as the independent registered public accounting firm, and endorsed the compensation plan for named executive officers during their 2026 Annual Meeting. All management proposals received strong support, indicating broad backing for the company's existing governance structure and leadership.
Planet Labs (PL) Is Down 6.6% After Launching $1.5 Billion ATM Stock Offering And Raising Guidance
Planet Labs PBC (PL) has seen its stock drop by 6.6% after launching a $1.5 billion at-the-market (ATM) stock offering, despite raising its revenue guidance for Q2 and fiscal 2027. The offering aims to fund the expansion of its high-resolution satellite fleet and AI products, but investors are weighing the potential dilution and ongoing losses against the company's growth prospects and new technology like Pelican-11. The article highlights the importance of Planet's ability to scale its earth imagery and AI products into a larger subscription business, emphasizing execution on long-term contracts as a key catalyst.
Planet Labs (PL) director sells 11,500 shares under Rule 10b5-1 plan
Planet Labs PBC director Brennan Ita M sold 11,500 shares of Class A Common Stock on July 1, 2026, at a weighted average price of $32.9978 per share. This sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on January 14, 2026. Following the transaction, Brennan Ita M directly holds 252,658 shares, including 32,468 Restricted Stock Units (RSUs).
Planet Labs (PL) Announces $1.5B Stock Offering, Shares Drop 5.4%
Planet Labs PBC announced a $1.5 billion equity distribution agreement for Class A common stock, facilitated by Goldman Sachs and Morgan Stanley. Following this news, PL shares dropped 5.4% in premarket trading, reflecting investor concerns over potential dilution and the company's financial health, which includes negative earnings and high debt. The company, valued at a high price-to-sales ratio of 43.57 and a GF Score of 54, faces challenges despite its growth potential in Earth-imaging services.
Planet Labs PBC Class A Actuals & Estimates (BOATS:PL)
This article provides an overview of Planet Labs PBC (BOATS:PL) stock, including financial actuals and analyst estimates. It covers historical price data, future price forecasts, earnings reports, revenue, net income, and employee count. The article also addresses frequently asked questions about the company's stock and financial performance.
85H1 Forecast — Price Target — Prediction for 2027
This article provides a forecast and price target for Planet Labs PBC Class A (85H1) stock, indicating a current price of 24.800 EUR and a 1-year analyst price target of 35.38 EUR. It also details financial metrics, past performance, and answers frequently asked questions regarding the stock, including its volatility, market cap, earnings, and revenue.
Precision Trading with Planet Labs Pbc Class A (PL) Risk Zones
This article provides a precision trading analysis for Planet Labs Pbc Class A (PL), highlighting weak near and mid-term sentiment but a strong long-term outlook. It outlines institutional trading strategies, including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for support and resistance levels. The report emphasizes the current signals and risk parameters generated by AI models.
Planet Labs PBC Class A Actuals & Estimates (FWB:85H1)
This article provides financial actuals and estimates for Planet Labs PBC Class A (FWB:85H1), including its current stock price, historical performance, analyst forecasts, and various financial metrics. It details the company's earnings, revenue, market capitalization, and volatility, highlighting a recent decrease in stock price and a strong sell signal from technical analysis.
Planet Labs PBC Class A Actuals & Estimates (HAM:85H1)
This article provides financial actuals and estimates for Planet Labs PBC Class A (HAM:85H1), including its current stock price, historical performance, analyst forecasts, and key financial metrics like revenue, net income, and EBITDA. It notes the stock's recent decline but an annual increase, with upcoming earnings scheduled for September 14, 2026. The stock does not pay dividends and has a market capitalization of 8.31 B EUR.
85H1 Forecast — Price Target — Prediction for 2027
This article provides a detailed forecast for Planet Labs PBC Class A (85H1) stock, including price targets from analysts, historical price performance, and key financial metrics. It also answers frequently asked questions about the stock, such as its current price, market capitalization, earnings, and volatility, and offers guidance on how to interpret its technical analysis for potential investment decisions.
Analysts Offer Insights on Industrial Goods Companies: Bloom Energy (BE), Equifax (EFX) and Planet Labs PBC (PL)
This article provides analyst insights on three industrial goods companies: Bloom Energy (BE), Equifax (EFX), and Planet Labs PBC (PL). Morgan Stanley maintained a "Buy" rating for Bloom Energy with a $310 price target, and reiterated a "Buy" for Equifax with a $243 price target. For Planet Labs PBC, Morgan Stanley maintained a "Hold" rating with a $35 price target.
Analysts Offer Insights on Industrial Goods Companies: Bloom Energy (BE), Equifax (EFX) and Planet Labs PBC (PL)
Morgan Stanley analysts have provided insights on several industrial goods companies. David Arcaro maintained a Buy rating for Bloom Energy (BE) with a $310 price target. Toni Kaplan reiterated a Buy rating for Equifax (EFX) with a $243 price target, while Kristine Liwag maintained a Hold rating for Planet Labs PBC (PL) with a $35 price target.
Top 10 most-bought ETFs: May 2026
In May 2026, investors showed a strong preference for sector and thematic ETFs, with VanEck Space Innovators ETF and VanEck Semiconductor ETF gaining significant traction due to interest in space and AI-related themes. Alongside these, traditional broad market ETFs like Vanguard FTSE All-World and S&P 500 funds remained popular, while precious metals ETFs for gold and silver also held their position despite recent downturns. The report highlights a tactical shift towards specialized funds alongside persistent interest in conventional trackers.
ETFs Investing in Planet Labs PBC Class A Stocks
This article lists various Exchange Traded Funds (ETFs) that hold Planet Labs PBC Class A stocks. It provides a detailed table including each fund's market value, weight of Planet Labs stock, issuer, management style, expense ratio, AUM, price, and YTD return, helping investors identify funds with exposure to Planet Labs. The list includes both broad market and specialized thematic ETFs, offering options for different investment strategies.
Planet Labs PBC Class A Balance Sheet – XETR:85H1
This article presents the balance sheet information for Planet Labs PBC Class A (XETR:85H1) through the first quarter of 2026. It highlights that the company's total assets for Q1 2026 reached €1.07 billion, marking a 10.33% increase from Q4 2025. Conversely, total liabilities decreased by 14.77% in Q1 2026, settling at €688.53 million.
Planet Labs (NYSE: PL) launches $1.5B ATM and range forward plan
Planet Labs PBC has established an "at-the-market" (ATM) equity program to offer and sell up to $1.5 billion of its Class A common stock. This program allows the company to raise capital flexibly over time through sales agents or via range forward sale agreements. Commissions for these transactions will not exceed 2%.
Planet Labs (NYSE: PL) seeks up to $1.5B via ATM and range-forward deals
Planet Labs PBC (NYSE: PL) has filed a prospectus supplement to offer up to $1.5 billion in Class A common stock through an at-the-market equity distribution agreement and range forward sale agreements. The company plans to use the net proceeds to fund future growth, including potential acquisitions, and for general corporate and working capital purposes. This offering may result in dilution to existing shareholders, with an illustrative dilution of $38.75 per share based on an assumed price of $43.53 per share if the full $1.5 billion is sold.
Planet Labs PBC (NYSE: PL) files S-3 shelf to sell Class A shares over time
Planet Labs PBC (NYSE: PL) has filed an S-3 shelf registration statement, effective June 5, 2026, to allow for the future sale of its Class A common stock and other securities. The company, a well-known seasoned issuer, intends to use the net proceeds for working capital and general corporate purposes, with specific offering terms and quantities detailed in future prospectus supplements. The filing outlines the company's capital structure, including 631.5 million authorized shares across Class A, B, and C common stock and preferred stock, and restates governance provisions like a multi-class stock structure and anti-takeover measures.
Planet Labs PBC Class A Trade Ideas — XETR:85H1
This article compiles various trade ideas and analyses for Planet Labs PBC (XETR:85H1 / NYSE:PL), highlighting its upcoming Q1 2027 earnings report, strategic focus on government contracts, and commercial potential. Analysts discuss stock performance, profitability challenges due to high investment costs, and technical setups like bullish flags and channel support. The article also touches on the company's valuation, its role in geospatial intelligence, and the broader context of the space sector.
